commencing with its Antiretroviral drDuovir-N, a fixed dose combination of 3 drugs, Zidovudine, Lamivudine and Nevirapine and thereafter

its ACT, which consists of Artemether and After its commissioning, the facility underwent an intensive validation phase aimed at ensuring that all equipments and systems that were installed met the required standards of Good Manufacturing Practice. This took up the better time of 2008 and culminated in receipt of various regulatory approvals from National thereafter its ACT, Lumartem